Trials / Conditions / Advanced or Recurrent Solid Tumors
Advanced or Recurrent Solid Tumors
5 registered clinical trials studyying Advanced or Recurrent Solid Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | EVM16 Injection As a Single and Combination with Tislelizumab in Solid Tumors NCT06541639 | Peking University | Phase 1 |
| Withdrawn | Comparison of Safety and Clinical Benefit of Injections Subcutaneously Talazoparib Versus Oral Talazoparib in NCT03426254 | Center Trials & Treatment | Phase 1 |
| Recruiting | NCCH2006/MK010 Trial (FORTUNE Trial) NCT04962867 | National Cancer Center, Japan | Phase 2 |
| Completed | Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors NCT01286987 | Pfizer | Phase 1 |
| Completed | Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid T NCT01285453 | Novartis Pharmaceuticals | Phase 1 |